GSMA
25.2.2020 13:02:04 CET | Business Wire | Press release
The GSMA today announced winners of the 2020 Global Mobile (GLOMO) Awards. The GLOMOs showcase those companies and individuals that are driving innovation in the rapidly evolving mobile industry.
“Our congratulations to all of the winners and nominees of the GSMA’s GLOMO Awards 2020,” said John Hoffman, CEO, GSMA Ltd. “The GLOMOs are a testament to the incredible innovation and ingenuity shaping our industry and it is truly an outstanding achievement to have been selected by our esteemed judging panels. We thank all of our entrants, judges, sponsors and partners for supporting the 2020 GLOMOs.”
The winners of the 2020 GLOMO Awards are:
Best Mobile Network Infrastructure
Vodafone, Parallel Wireless and Telecom Infra Project for Global OpenRAN Deployments
Best Mobile Technology Breakthrough (Companies > $10million Annual Global Revenue)
Ericsson for Ericsson Spectrum Sharing (ESS)
Best Mobile Technology Breakthrough (Companies < $10million Annual Global Revenue)
KaiOS for KaiOS, Enable Tomorrow
Best Network Software Breakthrough (Companies > $10million Annual Global Revenue)
Parallel Wireless for OpenRAN Controller and Network Software
Best Network Software Breakthrough (Companies < $10million Annual Global Revenue)
Cohere Technologies for Improved 4G and 5G FDD/TDD Networks
Best Mobile Authentication & Security Solution
Nuance Communications Inc. for Nuance Gatekeeper
5G Leadership Award
Huawei for Gear up with Huawei’s E2E 5G Products
5G Industry Partnership Award
China Unicom, BMW & Huawei for 5G Digital Factory Enable Automobile Manufacturing Digital Transformation
Outstanding Mobile Technology Award
Ericsson for Ericsson Spectrum Sharing (ESS)
Best Mobile Operator Service for Consumers
Vimplecom for Beeline & Liza Alert
Best Mobile service for the Connected Life
CalAmp for Here Comes The Bus
Most Innovative Mobile App
Turkcell for BiP Translate
Best Mobile Innovation for Work
China Eastern Airlines, China Unicom & Huawei for 5G Smart Travel in Airport
Best Mobile Innovation for Health and Biotech
Flare for World-Class Emergency Response Technologies
Best Mobile Innovation for Automotive
SK Telecom for Smart Fleet: Data Analytics Platform for Intelligent Mobility
Best Mobile Innovation for Payment and FinTech
Juvo for Financial Identity as a Service (FiDaaS)
Best Mobile Innovation for Smart Cities
China Mobile Group Zhejiang and Huawei for NB-IoT Smart City Fire Control
Best Mobile Innovation for Media and Entertainment
LG Uplus for U+VR 5G
Best Mobile Innovation for Building Trust in the Digital Age
Samsung Electronics for Knox Security Platform
Tech of the Future Award
Huawei for Atlas 900 AI Cluster - The Pinnacle of AI Compute for Future Inclusion
Best Smartphone
OnePlus for OnePlus 7T Pro
Disruptive Device Innovation Award
Qualcomm for Qualcomm Snapdragon X55 5G modem
Best Connected Consumer Device
Vasco Electronics for Vasco Mini2
Best Mobile Innovation for Emerging Markets
Safaricom for DigiFarm
Best Mobile Innovation supporting Emergency or Humanitarian Situations
MapSwipe for Missing Maps
Best Mobile Innovation for Accessibility & Inclusion
SK Telecom for Driving Assistance Solution for Hearing-Impaired Taxi Driver
Best Mobile Innovation for Climate Action
Huawei for Huawei PowerStar™ Solution, 3-Level AI-Based Energy Saving solution
Best Mobile Initiative for Enhancing Children’s Lives
Accenture for SAATHI – Autism Therapy at your Fingertips
Outstanding Mobile Contribution to the UN SDGs
KT for Global Epidemic Prevention Platform
Government Leadership Award
The Government of the Kingdom of Saudi Arabia
Outstanding Contribution to the Mobile Industry
Safaricom
Women4Technology – Industry Leadership Award
Elena Sinel, Founder for Teens In AI
Diversity in Tech Award
Teens In AI for Teens In AI
25 Years of Connecting People Award
Dr Mike Short - A constant champion of the role of mobile technology for the enhancement of society
YoMo STEAM Activity for Children Award
SK Telecom for Happy Coding School for Adolescents with Special Needs
For further information on GLOMO Awards winners please visit https://www.globalmobileawards.com/
- ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200225005494/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom